NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Culture Biosciences

Culture Biosciences

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.culturebiosciences.com/

Last Round

Series C

Dec 16, 2025

Est. Valuation

$1.71M

Total Funding Raised

$100.62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Culture Biosciences is a biotechnology company that develops automated bioreactors and cloud-native software to optimize manufacturing processes for sensitive cell cultures and high cell density fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

bioreactorbioprocessingcell culturecloud-integrated bioreactorbiotech lab automationprocess developmentbioreactor-as-a-servicedigital twindesign of experimentsDOEbiopharma R&Dlab-on-a-cloudAI-driven bioprocessingremote lab monitoringcell therapy manufacturingsmart manufacturingbiotech SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Culture Biosciences Comps

Public and private peers based on sector, stage, and business model.

Culture Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Culture Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 16, 2025
Series BOct 14, 2021
Series AMar 4, 2020
SeedFeb 12, 2019
AcceleratorJan 1, 2018

Key People

Founding team and executive leadership

Chris Williams

Chief Executive Officer

Executive Team

Culture Biosciences Investors

Notable investors and investment history

Culture Biosciences investors
InvestorRounds
S32Series A, Series B, Series C, Seed
Refactor CapitalSeed
The Production BoardSeries A, Series B
Synthesis CapitalSeries B, Series C
Cultivian Sandbox VenturesSeries B, Series C, Series A
Craft VenturesSeries B
Northpond VenturesSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Mike Stapleton appointed to the Board of Directors.

  • Dec 16, 2025

    Raised Series C round with participation from S32 and Northpond Ventures.

Culture Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Culture Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Culture Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range67
Year Founded2016
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.